COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence

How to cite this article: Mungmunpuntipantip R, Wiwanitkit V. COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence. Indian J Crit Care Med 2023;27(8):599.

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452765/
https://www.ncbi.nlm.nih.gov/pubmed/37636846
http://dx.doi.org/10.5005/jp-journals-10071-24499
_version_ 1785095753008414720
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description How to cite this article: Mungmunpuntipantip R, Wiwanitkit V. COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence. Indian J Crit Care Med 2023;27(8):599.
format Online
Article
Text
id pubmed-10452765
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-104527652023-08-26 COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Indian J Crit Care Med Letter to the Editor How to cite this article: Mungmunpuntipantip R, Wiwanitkit V. COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence. Indian J Crit Care Med 2023;27(8):599. Jaypee Brothers Medical Publishers 2023-08 /pmc/articles/PMC10452765/ /pubmed/37636846 http://dx.doi.org/10.5005/jp-journals-10071-24499 Text en Copyright © 2023; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2023 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title_full COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title_fullStr COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title_full_unstemmed COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title_short COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
title_sort covid-19 vaccine associated with cutaneous involvement: correspondence
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452765/
https://www.ncbi.nlm.nih.gov/pubmed/37636846
http://dx.doi.org/10.5005/jp-journals-10071-24499
work_keys_str_mv AT mungmunpuntipantiprujittika covid19vaccineassociatedwithcutaneousinvolvementcorrespondence
AT wiwanitkitviroj covid19vaccineassociatedwithcutaneousinvolvementcorrespondence

Ejemplares similares